News

Analysts Anticipate Strong Q3 Earnings for Texas Instruments

Analysts Anticipate Strong Q3 Earnings for Texas Instruments

Texas Instruments Set to Reveal Earnings Performance

Texas Instruments Incorporated (NASDAQ: TXN) is gearing up to announce its earnings results for the third quarter soon. Industry experts are closely watching this announcement, anticipating a positive outcome.

Expected Earnings and Revenue Growth

Forecasts suggest that Texas Instruments will report earnings of around $1.49 per share. This marks a slight increase from $1.47 per share in the same quarter last year. The projected revenue for this quarter is approximately $4.64 billion, a significant rise from $4.15 billion during the previous year, indicating strong growth in demand for their products.

Leadership Changes at Texas Instruments

In recent company news, Texas Instruments announced that its CEO, Haviv Ilan, will also take on the role of board chairman, effective in early 2026. This leadership transition follows the tenure of Rich Templeton, who has been influential in steering the company toward success.

Stock Performance Leading Up to Earnings

On the trading forefront, shares of Texas Instruments experienced a boost, rising by 1.7% to a closing price of $179.59 recently. This uptick reflects positive investor sentiment as the earnings call approaches.

Analytical Insights from Experts

As part of the preparation for the earnings announcement, analysts from various firms have weighed in on their expectations for the company. Let's delve into what some of the most accurate analysts are predicting:

  • Mizuho analyst Vijay Rakesh recently downgraded the stock from Neutral to Underperform, lowering their price target from $200 to $150, showing an accuracy rate of 79%.
  • Stifel analyst Tore Svanberg maintained a Hold rating while reducing the price target from $192 to $185, with an accuracy rate of 81%.
  • Citigroup analyst Christopher Danely has kept a Buy rating but adjusted the price target down from $260 to $235, maintaining a 79% accuracy rate.
  • B of A Securities analyst Vivek Arya downgraded the stock from Neutral to Underperform, cutting the price target from $208 to $190, showing an 81% accuracy rate.
  • Morgan Stanley analyst Joseph Moore retained an Underweight rating and lowered their price target from $197 to $192, with a 75% accuracy rating.

Understanding Analyst Sentiments

For potential investors considering TXN stock, these analyst opinions provide valuable insight. It’s essential to take into account both the earnings expectations and the current market perceptions when making investment decisions.

Frequently Asked Questions

What are Texas Instruments' expected Q3 earnings?

Analysts expect Texas Instruments to report earnings of about $1.49 per share for the third quarter.

How much revenue is Texas Instruments projected to earn?

The projected revenue for Texas Instruments this quarter is approximately $4.64 billion.

Who is the new chairman of Texas Instruments?

CEO Haviv Ilan will assume the role of board chairman starting in January 2026.

What has been the recent stock performance of Texas Instruments?

Texas Instruments shares recently rose by 1.7%, closing at $179.59.

What insights do analysts provide about Texas Instruments?

Analysts have provided varied ratings, with some downgrades but also maintained positive outlooks reflecting differing market sentiments.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 4

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 5

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 9

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 4

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading
Farm Aid 2026: A Resilient Tribute to Family Farmers

Updated Category News Views 4

Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 3

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 5

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 5

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 3

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Developments at West Harbor with New Tenant Additions

Updated Category News Views 286

West Harbor's Phase 2 Development Unveiled West Harbor, the incredible waterfront destination, is on the brink of major expansion as it accelerates its Phase 2 development. With plans to incorporate more than 125,000 square feet of new tenant leases, this project is set to transform the LA Waterfront into a vibrant hub for entertainment and dining experiences. New...

Continue Reading
CARVYKTI® Cell Therapy Shatters Survival Records in Myeloma Care

Updated Category News Views 218

CARVYKTI® got its moment in the sun after the CARTITUDE-4 study dropped some serious data on treating multiple myeloma back in 2024. This ain't just another therapy; it's the first cell treatment that showed it can really boost survival rates for patients who’ve been through the wringer—those dealing with relapsed or lenalidomide-refractory cases. Yeah, you heard...

Continue Reading
Understand Your Rights with Edwards Lifesciences Corporation

Updated Category News Views 300

Holding Edwards Lifesciences Accountable In the context of the ongoing financial landscape, it's essential to stay informed, especially if you have investments in significant firms like Edwards Lifesciences Corporation (NYSE: EW). Investors who feel they have suffered losses due to any potential mismanagement by company executives should take active steps to understand...

Continue Reading
Top Biotechnology Stocks Gaining Momentum You Should Know

Updated Category News Views 270

Recent Momentum in the Biotechnology Sector The biotechnology sector has been buzzing with activity, particularly in the realm of momentum stocks. Amidst strong technical indicators, four standout stocks have captured the attention of investors. These stocks are not only exhibiting positive price movement but are also entering elite percentile ranks for momentum gains....

Continue Reading
STMicroelectronics Secures $1.2 Billion Funding for Growth

Updated Category News Views 93

STMicroelectronics Expands Funding for Future Technologies STMicroelectronics NV (NYSE: STM) has recently secured a significant financing agreement with the European Investment Bank, aimed at enhancing research and development (R&D) initiatives, as well as expanding manufacturing capacity across Europe. Details of the Financing Agreement The European Investment Bank...

Continue Reading